Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy

Condition:   Buruli Ulcer Interventions:   Drug: Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks.;   Drug: Investigational [RCA4]: standard (RC) plus amoxicillin/clavulanate (A) for 4 weeks. Sponsors:   Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID);   Universidad de Zaragoza;   Fondation Raoul Follereau;   Université d'Abomey-Calavi;   Instituto de Salud Carlos III;   Fundación Anesvad Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials